NCT01209624View on ClinicalTrials.gov

Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma

CompletedOBSERVATIONAL
Enrollment

902

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Low Tension Glaucoma
All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01209624 - Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma | Biotech Hunter | Biotech Hunter